Contact us for free information or to start a free case review.
The Food and Drug Administration said this week that it was conducting a safety review of Spiriva, a respiratory drug administered by way of an inhaler, after studies linked it to a slightly higher risk of stroke.
Spiriva is used to treat chronic obstructive pulmonary disease (COPD), a condition commonly caused by smoking. COPD is one of the leading causes of death in the United States.
Study Results
Boehringer Ingelheim, the maker of Spiriva, submitted the results of more than two dozen studies on the drug to the FDA. Most of the studies involved the Spiriva HandiHaler.
Preliminary findings showed that Spiriva increased the risk of stroke for an additional two patients per 1,000 per year when compared with placebo.
More Information Needed
“Additional information is needed to further evaluate this preliminary information about stroke in patients who take Spiriva HandiHaler,” the FDA said in a statement.
Results of a more extensive four-year study on the drug are expected to be released in June.
(Source: The Wall Street Journal)
Injured by a defective drug? Contact us today to find an experienced attorney near you and learn more about your legal rights and options.
Copyright © 2001 - 2012 Online Lawyer Source
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.